In a recent announcement, the Centers for Medicare & Medicaid Services (CMS) underscored its commitment to ensuring continued access to essential blood tests for Medicare beneficiaries with transplanted hearts, lungs, or kidneys.
These blood tests, vital for monitoring organ rejection, remain available to patients who meet specific coverage criteria and have been prescribed by their physicians in medically appropriate circumstances. The clarification comes after CMS, through its local contractors—known as Medicare Administrative Contractors (MACs)—updated billing instructions in March 2023 to combat issues of improper billing and overutilization.
The action by CMS reaffirms the agency’s dedication to patient care and the precise billing practices required in the healthcare system. These billing instructions are crucial for healthcare providers, outlining the correct procedures for billing Medicare for covered services. The recent updates made by the MACs aim to rectify any confusion that might have arisen from earlier billing articles, ensuring that both physicians and patients understand that these critical tests are still accessible when deemed medically necessary.
Background information provided by CMS highlights the role of the MACs in developing local coverage determinations (LCDs). These LCDs guide the coverage of specific services in their jurisdictions, provided they do not conflict with national coverage policies. One innovative initiative, the Molecular Diagnostic Services Program (MolDX), developed by Palmetto GBA, a MAC, exemplifies efforts to establish coverage and payment for molecular diagnostic tests. This program and similar efforts by other MACs emphasize the technical and specialized nature of evaluating molecular diagnostics and technology, incorporating insights from laboratory medicine and genomics.
The necessity for the revised billing and coding article, issued on March 31, 2023, emerged from observations of improper billing practices and the overutilization of certain tests, which did not align with the coverage guidelines outlined in the LCD. The MACs sought to distinguish between surveillance tests (conducted as part of a protocol) and for-cause tests (initiated due to symptoms of rejection), with the goal of ensuring that laboratory billing practices adhered to Medicare requirements. The feedback from various stakeholders prompted the MACs to revise the article, reintroducing a table that lists the solid organ allograft rejection tests covered under the indications specified in the LCD.
Further, CMS and the MACs have demonstrated a willingness to engage with the medical community and the public on these critical issues. For instance, on Aug. 10, 2023, the MACs released a proposed LCD inviting comments and evidence from the public regarding proposed changes aimed at clarifying existing coverage policies. The period for public comment, which ended on Sept. 23, 2023, reflects the open approach by CMS to policy development, ensuring that decisions are informed by a broad range of perspectives and evidence.
As the MACs review public comments and clinical evidence submitted in response to the proposed LCD, the healthcare community awaits further guidance.
Recent actions by CMS, including the issuance of the revised billing article, signal a clear expectation that physicians will continue prescribing these essential post-transplant tests for eligible patients. Looking ahead, the finalization of the proposed LCD will lead to the issuance of a final LCD that explains the rationale behind coverage decisions, accompanied by a new billing and coding article to further educate healthcare providers about the proper coding and billing procedures for these tests.
In summary, the efforts by CMS to clarify billing instructions for blood tests used to monitor for organ transplantation rejection underscore its commitment to ensuring that Medicare beneficiaries continue to have access to necessary medical care. By addressing challenges related to improper billing and overutilization, and by fostering open dialogue with the healthcare community and the public, CMS is taking significant steps to support patient care and the sustainability of the Medicare program.
Rule 9(b) of the Federal Rules of Civil Procedure states that, in all averments of fraud, such as allegations concerning the False Claims Act, (FCA)
“Inattentional blindness” is a fancy term to describe a very real compliance risk. There’s a great video illustrating the problem which will appear at the
Please log in to your account to comment on this article.
Optimize your outpatient clinical documentation and gain comprehensive knowledge from foundational practices to advanced technologies, ensuring improved patient care and organizational and financial success. This webcast bundle provides a holistic approach to outpatient CDI, empowering you to implement best practices from the ground up and leverage advanced strategies for superior results. You will gain actionable insights to improve documentation quality, patient care, compliance, and financial outcomes.
Enhancing outpatient clinical documentation is crucial for maintaining accuracy, compliance, and proper reimbursement in today’s complex healthcare environment. This webcast, presented by industry expert Angela Comfort, DBA, RHIA, CDIP, CCS, CCS-P, will provide you with actionable strategies to tackle complex challenges in outpatient documentation. You’ll learn how to craft detailed clinical narratives, utilize advanced EHR features, and implement accurate risk adjustment and HCC coding. The session also covers essential regulatory updates to keep your documentation practices compliant. Join us to gain the tools you need to improve documentation quality, support better patient care, and ensure financial integrity.
This webcast, presented by Angela Comfort, DBA, RHIA, CDIP, CCS, CCS-P, a recognized expert with over 30 years of experience, offers essential strategies to improve outpatient clinical documentation integrity. You will learn how to enhance the accuracy and completeness of patient records by adopting best practices in coding and incorporating Social Determinants of Health (SDOH). The session also highlights the role of technology, such as EHRs and CDI software, in improving documentation quality. By attending, you will gain practical insights into ensuring precise and compliant documentation, supporting patient care, and optimizing reimbursement. This webcast is crucial for those looking to address documentation gaps and elevate their coding practices.
ICD10monitor has teamed up with renowned CDI expert Dr. Erica Remer to bring you an exclusive webcast on how to recognize sepsis, how to get providers to give documentation that will support sepsis, and how to educate to avert sepsis denials. Register now and become a crucial piece of the solution to standardizing sepsis clinical practice, documentation, and coding at your facility.
Protect your facility from unwanted audits! Join Becky Jacobsen, BSN, RN, MBS, CCS-P, CPC, CPEDC, CBCS, CEMC, and take a deep dive into both the CMS and AMA guidelines for reporting post operative pain blocks. You’ll learn how to determine if the nerve block is separately codable with real life examples for better understanding. Becky will also cover how to evaluate whether documentation supports medical necessity, offer recommendations for stronger documentation practices, and provide guidance on educating providers about documentation requirements. She’ll include a discussion of appropriate modifier and diagnosis coding assignment so that you can be confident that your billing of post operative pain blocks is fully supported and compliant.
During this RACmonitor webcast Dr. Ronald Hirsch spotlights the areas of the OIG’s Work Plan and the findings of their most recent audits that impact utilization review, case management, and audit staff. He also provides his common-sense interpretation of the prevailing regulations related to those target issues. You’ll walk away better equipped with strategies to put in place immediately to reduce your risk of paybacks, increased scrutiny, and criminal penalties.
This webcast, presented by Tiffany Ferguson, LMSW, CMAC, ACM, addresses the critical gap in Social Determinants of Health (SDoH) reporting for pediatric populations. While SDoH efforts often focus on adults, this session emphasizes the unique needs of children. Attendees will gain insights into the current state of SDoH, new pediatric Z-codes, and the importance of interdisciplinary collaboration. By understanding and applying pediatric-specific SDoH factors, healthcare professionals can improve data capture, compliance, and care outcomes. This webcast is essential for those looking to enhance their approach to pediatric SDoH reporting and coding.
Join Becky Jacobsen, BSN, RN, MBS, CCS-P, CPC, CPEDC, CBCS, CEMC, VP of CDM, for a webcast addressing oncology service coding challenges. Learn to navigate coding for infusions and injections alongside Evaluation and Management (E/M) services, ensuring compliance and accurate reimbursement. Gain insights into documenting E/M services for oncology patients and determining medical necessity. This webcast is essential to optimize coding practices, maintain compliance, and maximize revenue in oncology care.
Copyright © 2024 RACmonitor. Powered by MedLearn Media.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
